Vimarsana
Biggest News Aggregation in the World

Page 11 - Cell Proliferation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Proliferation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Proliferation Today - Breaking & Trending Today

12 Peking University Professors Died after New Year, All Were Chinese Communist Party Members - Vimarsana News

12 Peking University Professors Died after New Year, All Were Chinese Communist Party Members

Peking University has been hit hard amidst the latest COVID-19 outbreak, which began at the end of 2022. ...

Scientists illuminate the mechanisms that prevent p53 activation from triggering cancer cell death - Vimarsana News

Scientists illuminate the mechanisms that prevent p53 activation from triggering cancer cell death

Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors and oncogenes.

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly - Vimarsana News

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly

Microtubules are cellular fibres that are part of the skeleton of the cell, termed cytoskeleton. They ensure that cells maintain their shape, carry out their functions, and divide.

Chemotherapy in the afternoon proved to be effective for female lymphoma patients - Vimarsana News

Chemotherapy in the afternoon proved to be effective for female lymphoma patients

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are highly effective at killing cancer cells, they are also notorious for killing healthy cells in the body.

Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III - Vimarsana News

Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III

BERLIN, Germany, January 26, 2023 / B3C newswire / -- ProBioGen today announced that a Novartis clinical candidate using its antibody-dependent cellular cytotoxicity (ADCC) technology, GlymaxX, has reached Phase III.ProBioGen's mission is to contribute towards the development of medicines against complex diseases. T...